Recent Publications on Hairy Cell Leukemia: |  |
Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab.
A better understanding of the medical-legal considerations of the medical...
Direct Link | 18th September, 2008
|
|
Hairy Cell Leukemia: Current Concepts.
Hairy cell Leukemia (HCL) is a chronic lymphoproliferative disorder that...
Direct Link | 18th September, 2008
| Division of Hematology/Oncology, George Washington University Medical
|
An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes.
Recombinant immunotoxins are hybrid proteins composed of an Fv that binds...
Direct Link | 17th September, 2008
| Laboratory of Molecular Biology, Center for Cancer Research, National
|
| Hairy Cell Leukemia with Unusual Loss of CD103 in a Subset of the Neoplastic Population: Immunophenotypic and Cell Cycle Analysis by Flow Cytometry.
| 13th September, 2008
|
|
Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control study.
OBJECTIVE: To study potential role of smoking and alcohol in lymphoid...
Direct Link | 11th September, 2008
| Inserm U754, 94800,
|
Expression of Activation-induced Cytidine Deaminase in Malignant Lymphomas Infiltrating the Bone Marrow.
Somatic hypermutation of immunoglobulin genes and class switch...
Direct Link | 9th September, 2008
| *Senckenbergisches Institut fur Pathologie, Klinikum der Johann Wolfgang
|
Underexpression of RhoH in Hairy Cell Leukemia.
The cause of hairy cell leukemia (HCL) is unknown. Current treatments seem...
Direct Link | 19th August, 2008
| Institut National de la Sante et de la Recherche Medicale U.837, Centre
|
| Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients.
| 23rd July, 2008
| Division of Hematopathology, Mayo Clinic, Rochester, MN 55905, USA.
|
A novel CD11c monoclonal antibody effective in formalin-fixed tissue for the diagnosis of hairy cell leukemia.
OBJECTIVE: The diagnosis of hairy cell leukemia (HCL) and its distinction...
Direct Link | 23rd July, 2008
| Institute of Pathology and Reference Center for Hematopathology, Charite,
|
| Hairy cell leukemia: Clinical, pathological and ultrastructural findings in Asian-Indians.
| 16th July, 2008
| Department of Hematology, AIIMS, Ansari Nagar, New Delhi-110 029, India.
|
| Review: isolated skeletal involvement in hairy cell leukemia.
| 9th July, 2008
| Department of Hematology and Oncology, Arthur G. James Comprehensive
|
Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98).
OBJECTIVE: To study the effectiveness of peripheral blood (PB) and bone...
Direct Link | 8th July, 2008
|
|
Soluble CD22 as a tumor marker for hairy cell leukemia.
CD22 is an important immunotherapeutic target on B-cell malignancies,...
Direct Link | 4th July, 2008
| Laboratory of Molecular Biology, Center for Cancer Research, National
|
| [Complete remission after Rituximab treatment in refractory hairy cell leukemia]
| 4th July, 2008
| Arhus Universitetshospital, Aalborg Sygehus, Haematologisk Afdeling.
|
Hairy cell leukemia: treatment successes in the past 25 years.
The cause of hairy cell leukemia (HCL) is unknown. Current treatments seem...
Direct Link | 26th June, 2008
| University of Chicago, Chicago, IL, USA.
|
